More than 100 000 people in Sweden are living with a diagnosis of Alzheimer’s disease. There are currently no drugs that can slow down the progression of the disease. However, a lot of research is ongoing and despite major challenges and setbacks, the hope is that we are getting closer to a more effective treatment.
You will hear about the challenges that need to be solved for the paradigm shift a therapeutic drug for Alzheimer’s would represent. The day provides a unique opportunity to gain new knowledge, network and set the agenda for the future development of the Alzheimer’s field.
